 Wall Street brokerages expect Oramed Pharmaceuticals, Inc. NASDAQ:ORMP to announce 690,000.00 in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Oramed Pharmaceuticals earnings, with the highest sales estimate coming in at 700,000.00 and the lowest estimate coming in at 680,000.00. Oramed Pharmaceuticals posted sales of 680,000.00 ... 